Maria Barbara Nowakowska

Maria Barbara Nowakowska

Auto-generated profile, based on publicly available information

Maria Barbara Nowakowska

Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
LGLinfeng Gao
Linfeng Gao
MLMiia Lindström
Miia Lindström
KSKatja Selby
Katja Selby
APAdina Przykopanski
Adina Przykopanski
BCBaohua Chen
Baohua Chen
RJRongsheng Jin
Rongsheng Jin

27 January 2023 in FEBS Letters
Verified
Journal Article
Open access
LGLinfeng Gao
Linfeng Gao
KLKwok‐Ho Lam
Kwok‐Ho Lam
SLShun Liu
Shun Liu
APAdina Przykopanski
Adina Przykopanski
JLJohanna Lübke
Johanna Lübke
RJRongsheng Jin
Rongsheng Jin
Botulinum neurotoxins (BoNTs) are among the most lethal toxins known to humans, comprising seven established serotypes termed BoNT/A–G encoded in two types of gene clusters (ha and orfX) in BoNT‐producing clostridia. The ha cluster encodes four non‐toxic neurotoxin‐associated proteins (NAPs) that assemble with BoNTs to protect and enhance their oral toxicity. However, the structure and function of the orfX‐type NAPs remain largely unknown. Here, we report the crystal structures for OrfX1, OrfX2, and an OrfX1–OrfX3 complex, which are encoded in the orfX cluster of a BoNT/E1‐producing Clostridium botulinum strain associated with human foodborne botulism. These structures lay the foundation for future studies on the potential roles of OrfX proteins in oral intoxication and pathogenesis of BoNTs.

29 August 2025 in Science Advances
Verified
Journal Article
Open access
AKAjda Krč
Ajda Krč
SKSara Persson Košenina
Sara Persson Košenina
MLMiia Lindström
Miia Lindström
GMGeoffrey Masuyer
Geoffrey Masuyer
PSPål Stenmark
Pål Stenmark
Botulinum neurotoxin serotype B1 (BoNT/B) is a highly potent neurotoxin and therapeutic agent. Here, we present the structure of the complete 14-subunit (780 kDa) progenitor toxin complex (L-PTC) and of five subcomplexes. The structures show how the toxin interacts with its associated components in their role to protect and deliver BoNT/B across epithelial barriers. Each subcomplex, including the M-PTC, M-PTC–HA70, NTNH-HA70, and HA70 trimer, provides detailed understanding of the assembly mechanism, in which the NTNH-nLoop adopts a unique fold that locks the M-PTC into a central pore formed by HA70. The HA subcomplex presents a tripod architecture with flexible legs that may adapt to the rugged cell surface. Mass photometry reveals the pH dependence of BoNT/B release from the complex which is unexpectedly influenced by the presence of HA70. This study provides the complete L-PTC structure, offering insights into its assemblage and supporting the development of countermeasures and therapeutic applications.

19 December 2023 in mBio
Verified
Journal Article
Open access
AMAnna Mertaoja
Anna Mertaoja
GMGerald Mascher
Gerald Mascher
MNMaria B. Nowakowska
Maria B. Nowakowska
HKHannu Korkeala
Hannu Korkeala
AHAdriano O. Henriques
Adriano O. Henriques
MLMiia Lindström
Miia Lindström
Toxin production and sporulation are key determinants of pathogenesis in Clostridia. Clostridium botulinum produces the most potent toxin known, the botulinum neurotoxin (BoNT), which blocks neurotransmission and causes a life-threatening paralysis called botulism. BoNT production and sporulation share a common regulator Spo0A, which suggests coordination of the two traits. Describing the relationship between toxin production and sporulation is fundamental toward understanding the evolutionary and mechanistic logic and further control of clostridial pathogenesis. Here, we provide the first single-cell resolution analysis of BoNT production and sporulation in C. botulinum type E cultures by using a fluorescent reporter to follow the activation of the BoNT gene promoter. BoNT was expressed by a subpopulation of cells and was released through Spo0A-mediated autolysis of vegetative cells or upon release of mature spores. All possible combinations of toxin production and sporulation resided in wild-type C. botulinum type E cultures, indicating neither tight co-regulation nor strict independence of the two traits. The population structure and the degree of overall heterogeneity were affected by growth phase and environmental conditions, with cold temperature inducing large diversity and cultural stability, in line with adaptation to fluctuating temperatures that C. botulinum type E strains likely encounter in nature. We also observed Spo0A-independent BoNT production by a small cell subpopulation of the spo0A -null strain. Our observation of toxin gene activation in the forespore invites speculation on possible alternative biological roles for toxin production by vegetative and sporulating cells and reflection on the evolutionary rationale of toxin production with respect to the ecology of spore-forming pathogens. IMPORTANCE: Toxin production and sporulation are key determinants of pathogenesis in Clostridia . Toxins cause the clinical manifestation of clostridial diseases, including diarrhea and colitis, tissue damage, and systemic effects on the nervous system. Spores ensure long-term survival and persistence in the environment, act as infectious agents, and initiate the host tissue colonization leading to infection. Understanding the interplay between toxin production and sporulation and their coordination in bacterial cells and cultures provides novel intervention points for controlling the public health and food safety risks caused by clostridial diseases. We demonstrate environmentally driven cellular heterogeneity in botulinum neurotoxin and spore production in Clostridium botulinum type E populations and discuss the biological rationale of toxin and spore production in the pathogenicity and ecology of C. botulinum . The results invite to reassess the epidemiology of botulism and may have important implications in the risk assessment and risk management strategies in food processing and human and animal health.